| Literature DB >> 33544198 |
Agnieszka Szemraj-Folmer1, Anna Wojtaszek-Słomińska2, Bogna Racka-Pilszak2, Małgorzata Kuc-Michalska3.
Abstract
OBJECTIVES: The aim of the study is to assess the skeletal age at the onset and end of the pubertal growth spurt and determine its duration in four growth type groups: (1) normodivergent skeletal Class I (I N), (2) normodivergent skeletal Class III (III N), (3) high-angle skeletal Class III (III H) and (4) high-angle skeletal Class I (I H).Entities:
Keywords: Cephalometric measurements; Cervical vertebral maturation; Growth spurt; Growth spurt duration
Mesh:
Year: 2021 PMID: 33544198 PMCID: PMC8342358 DOI: 10.1007/s00784-021-03799-7
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.573
Fig. 1Cervical vertebral maturation method according to Baccetti, Franchi and McNamara (2005). Source: Baccetti T, Franchi L, McNamara JA Jr. (2005) The cervical vertebral maturation (CVM) method for the assessment of optimal treatment timing in dentofacial orthopedics. Seminars in orthodontics 11:119–129
Fig. 2Vertebral points, measures and ratios used to determine the vertebral stage in the CVM method. C3BAR: ratio between the length of the base (distance C3lp-C3la) and the anterior height (distance C3ua-C3la) of the body of C3. C3PAR: ratio between the posterior (distance C3up-C3lp) and anterior (distance C3ua-C3la) heights of the body of C3. C4BAR: ratio between the length of the base (distance C4lp-C4la) and the anterior height (distance C4ua-C4la) of the body of C4. C4PAR: ratio between the posterior (distance C4up-C4lp) and anterior (distance C4ua-C4la) heights of the body of C4. Source: Baccetti T, Franchi L, McNamara JA Jr. (2005) The cervical vertebral maturation (CVM) method for the assessment of optimal treatment timing in dentofacial orthopedics. Seminars in orthodontics 11:119–129
Descriptive statistics
| Gender | Type of malocclusion | CVM stage | No. of records | Mean age [year] | Standard deviation | Minimum age [year] | Maximum age [year] |
|---|---|---|---|---|---|---|---|
| Female + Male | I N | CS3 | 29 | 10.74 | 0.94 | 9 | 12 |
| CS4 | 29 | 11.81 | 1.41 | 9.33 | 14.92 | ||
| III N | CS3 | 25 | 11.94 | 1.47 | 9.92 | 14.75 | |
| CS4 | 25 | 13.5 | 1.42 | 11 | 16.33 | ||
| III H | CS3 | 28 | 10.72 | 1.7 | 7.42 | 13.58 | |
| CS4 | 25 | 13.4 | 1.81 | 10.08 | 17.42 | ||
| I H | CS3 | 25 | 11.49 | 1.51 | 8.75 | 14.5 | |
| CS4 | 27 | 13.76 | 1.86 | 9.5 | 17.42 | ||
| Female | I N | CS3 | 19 | 10.57 | 1.01 | 9 | 11.75 |
| CS4 | 17 | 11.5 | 1.24 | 9.33 | 14.5 | ||
| III N | CS3 | 13 | 11.17 | 1.51 | 9.92 | 14 | |
| CS4 | 13 | 13.19 | 1.16 | 11.92 | 14.92 | ||
| III H | CS3 | 20 | 10.16 | 1.56 | 7.42 | 12.67 | |
| CS4 | 14 | 12.95 | 0.93 | 11.5 | 14.5 | ||
| I H | CS3 | 14 | 11.14 | 1.4 | 8.75 | 13.67 | |
| CS4 | 19 | 13.82 | 1.85 | 9.5 | 17.25 | ||
| Male | I N | CS3 | 10 | 11.07 | 0.71 | 10.08 | 12 |
| CS4 | 12 | 12.26 | 1.57 | 10.75 | 14.92 | ||
| III N | CS3 | 12 | 12.54 | 1.2 | 11.25 | 14.75 | |
| CS4 | 12 | 13.85 | 1.64 | 11 | 16.33 | ||
| III H | CS3 | 8 | 12.11 | 1.19 | 9.92 | 13.58 | |
| CS4 | 11 | 13.96 | 2.48 | 10.08 | 17.42 | ||
| I H | CS3 | 11 | 11.95 | 1.58 | 9.42 | 14.5 | |
| CS4 | 8 | 13.63 | 2.03 | 11.75 | 17.42 |
The comparison of mean ages between CS3 and CS4 stages in groups with different types of malocclusion
| I N | III N | III H | I H | ||
|---|---|---|---|---|---|
| Male + Female | CS3 | 10.74 | 11.94 | 10.72 | 11.49 |
| CS4 | 11.81 | 13.5 | 13.4 | 13.76 | |
| 0.001* | < 0.001* | < 0.001* | < 0.001* | ||
| Female | CS3 | 10.57 | 13.38 | 10.16 | 11.14 |
| CS4 | 11.58 | 13.19 | 12.92 | 13.82 | |
| 0.019* | 0.002* | < 0.001* | < 0.001* | ||
| Male | CS3 | 11.07 | 12.54 | 12.11 | 11.95 |
| CS4 | 12.26 | 13.85 | 13.96 | 13.63 | |
| 0.031* | 0.037* | 0.069* | 0.058* | ||
The comparison of mean ages at CS3 and CS4 stages among groups with different types of malocclusion. ANOVA
| Gender | CVM stage | Mean age | Post-hoc Tukey HSD | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I N | III N | III H | I H | I N vs. III N | I N vs. III H | I N vs. I H | III N vs. III H | III N vs. I H | III H vs. I H | |||
| Male + Female | CS3 | 10.74 | 11.94 | 10.72 | 11.49 | 0.004* | 0.014* | 1 | 0.219 | 0.013* | 0.689 | 0.204 |
| CS4 | 11.81 | 13.5 | 13.4 | 13.76 | < 0.001* | 0.001* | 0.003* | < 0.001* | 0.996 | 0.941 | 0.853 | |
| Female | CS3 | 10.57 | 11.38 | 10.16 | 11.14 | 0.061 | ||||||
| CS4 | 11.5 | 13.19 | 12.95 | 13.82 | < 0.001* | 0.008* | 0.025* | < 0.001* | 0.972 | 0.586 | 0.295 | |
| Male | CS3 | 11.07 | 12.54 | 12.11 | 11.95 | 0.057 | ||||||
| CS4 | 12.26 | 13.85 | 13.96 | 13.63 | 0.141 | |||||||
The comparison of mean duration (in years) of pubertal growth spurt for different types of malocclusion. A linear model with interaction variables. CS4-CS3 – the difference between the means of the chronological age related to CS4 and CS3 (the duration of the pubertal growth spurt), F – result of ANOVA, df – degrees of freedom
| Type of malocclusion | CS4-CS3 [year] | F | df | |
|---|---|---|---|---|
| I N | 1.07 | 0.947 | 1, 104 | 0.333* |
| III N | 1.56 | |||
| I N | 1.07 | 8.03 | 1, 107 | 0.006* |
| III H | 2.68 | |||
| I N | 1.07 | 4.61 | 1, 106 | 0.034* |
| I H | 2.27 | |||
| III N | 1.56 | 3.05 | 1, 99 | 0.084 |
| III H | 2.68 | |||
| III N | 1.56 | 1.25 | 1, 98 | 0.265 |
| I H | 2.27 | |||
| III H | 2.68 | 0.365 | 1, 101 | 0.547 |
| I H | 2.27 |